EMAIL THIS PAGE TO A FRIEND

PloS one

Nonclinical evaluation of novel cationically modified polysaccharide antidotes for unfractionated heparin.


PMID 25781030

Abstract

Protamine, the only registered antidote of unfractionated heparin (UFH), may produce a number of adverse effects, such as anaphylactic shock or serious hypotension. We aimed to develop an alternative UFH antidote as efficient as protamine, but safer and easier to produce. As a starting material, we have chosen generally non-toxic, biocompatible, widely available, inexpensive, and easy to functionalize polysaccharides. Our approach was to synthesize, purify and characterize cationic derivatives of dextran, hydroxypropylcellulose, pullulan and γ-cyclodextrin, then to screen them for potential heparin-reversal activity using an in vitro assay and finally examine efficacy and safety of the most active polymers in Wistar rat and BALB/c mouse models of experimentally induced arterial and venous thrombosis. Efficacy studies included the measurement of thrombus formation, activated partial thromboplastin time, bleeding time, and anti-factor Xa activity; safety studies included the measurement of hemodynamic, hematologic and immunologic parameters. Linear, high molecular weight dextran substituted with glycidyltrimethylammonium chloride groups at a ratio of 0.65 per glucose unit (Dex40-GTMAC3) is the most potent and the safest UFH inhibitor showing activity comparable to that of protamine while possessing lower immunogenicity. Cationic polysaccharides of various structures neutralize UFH. Dex40-GTMAC3 is a promising and potentially better UFH antidote than protamine.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

74440
(−)-Nopol, purum, ≥98.0% (sum of enantiomers, GC)
C11H18O
448281
(3-Acrylamidopropyl)trimethylammonium chloride solution, 75 wt. % in H2O
C9H19ClN2O
705284
1,1′-Carbonyldiimidazole solution, 0.4 M in methylene chloride
C7H6N4O
284505
1,2-Dichloroethane, anhydrous, 99.8%
C2H4Cl2
34872
1,2-Dichloroethane, for HPLC, ≥99.8%
C2H4Cl2
02562
1,2-Dichloroethane, analytical standard
C2H4Cl2
07-2101
1,2-Dichloroethane, for HPLC
C2H4Cl2
216984
2-(4-Biphenyl)-5-phenyloxazole, 98%
C21H15NO
09743
3,3′,5,5′-Tetramethylbenzidine, standard for GC
C16H20N2
92264
4-Methoxyphenol, analytical standard
C7H8O2
54050
4-Methoxyphenol, purum, ≥98.0% (HPLC)
C7H8O2
M18655
4-Methoxyphenol, ReagentPlus®, 99%
C7H8O2
05810
Allylamine, purum, ≥98.0% (GC)
C3H7N
241075
Allylamine, ≥99%
C3H7N
145831
Allylamine, 98%
C3H7N
00213
Benzoyl peroxide blend with dicyclohexyl phthalate, technical, ~50% (T)
C14H10O4
B5907
Benzoyl peroxide blend with dicyclohexyl phthalate, suitable for use as a catalyst for electron microscopy. Modified to render it safe in transit.
C14H10O4
03378
Chloride atomic spectroscopy standard concentrate 10.00 g Cl-, 10.00 g/L, for 1 l standard solution, analytical standard
HCl
633178
Deuterium oxide, 99.994 atom % D, contains 1 mM terephthalic acid disodium salt, 0.01 % (w/v) DSS-d6
D2O
613398
Deuterium oxide, extra, 99.994 atom % D
D2O
191701
Deuterium oxide, "100%", 99.990 atom % D
D2O
364312
Deuterium oxide, standard, 99.98 atom %±0.01 atom % D
D2O
151890
Deuterium oxide, "100%", ≥99.96 atom % D
D2O
269786
Deuterium oxide, "100%", 99.96 atom % D
D2O
151882
Deuterium oxide, 99.9 atom % D
D2O
530867
Deuterium oxide, 99.9 atom % D
D2O
613444
Deuterium oxide, 99.9 atom % D, glass distilled
D2O
450510
Deuterium oxide, 99.9 atom % D, contains 0.05 wt. % 3-(trimethylsilyl)propionic-2,2,3,3-d4 acid, sodium salt
D2O
293040
Deuterium oxide, 99.9 atom % D, contains 0.75 wt. % 3-(trimethylsilyl)propionic-2,2,3,3-d4 acid, sodium salt
D2O
343773
Deuterium oxide, 99.9 atom % D, contains 1 % (w/w) 3-(trimethylsilyl)-1-propanesulfonic acid, sodium salt (DSS)
D2O